Addressing Health Inequities in Cancer
Gilead Sciences funds research and programs addressing social and economic barriers to health equity in cancer care for underserved communities in several countries.
Funder: Gilead Sciences
Due Dates: Rolling
Funding Amounts: Over $35 million awarded to date; typical award size and duration not specified; funding is for projects up to one year.
Summary: Supports programs addressing social and economic barriers to health equity in cancer care across the U.S., Australia, Canada, and Europe.
Description
The Gilead Oncology Grant aims to advance health equity for people impacted by cancer by funding programs that address and overcome social and economic barriers contributing to cancer disparities. The initiative is focused on ensuring equitable access to care and resources for underserved communities. Eligible projects may include community-based interventions, education, and support services that improve cancer outcomes for marginalized populations in the United States, Australia, Canada, and Europe. Since its inception, the program has awarded over $35 million in health equity-related oncology grants.
